History – Panacea

Our Story

The journey from 1999 to Infinity

Our Innovation History

1999

2002

2005

2006

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2023

1999

Establishment

In 1999, Panacea Medical technologies was established in Whitefield, Bangalore by a group of Technocrats

2002

Development of MV Linac

In 2002, As linear accelerators gained place in medicine, Panacea began the development of 6MV linear accelerator

2005

Commissioning of Bhabhatron

In 2005, was commissioned at ACTREC, Mumbai

2006

1st Installation

In 2006, Panacea installed its first Bhabhatron II in Indian Red Cross Society Cancer Hospital, Nellore. Andhra Pradesh

2008

Recognition

By 2008, Panacea was ISO certified and gained recognition by INS. Meanwhile, Panacea commercialized its Imagin Simulator

2009

CE Certification

In 2009, Panacea’s Bhabhatron II and Imagin got CE marked. The company was honoured by IERDA award for its contribution to society

2010

Vietnam

In 2010, Panacea installed Bhabhatron II in Vietnam, making it “the first international installation”

2011

R&D Facility

In 2011, DSIR recognized Panacea as an R&D facility

2012

Excellence

In 2012, Panacea was honored with the India SME excellence award in recognition of exemplary achievement in “Manufacturing sector”

2013

Quality Award

In 2013, Panacea Received quality award by Quality Council of India as recognition of Bhabhatron II’s success for cancer care

2014

Treating Lives

With the donation of Bhabhatron II and Imagin to Mongolia, Bhabhatron II had treated more than 100,000 patients by 2014

2015

66th Republic Day

In 2015, A proud moment for Panacea when Bhabhatron II was displayed on Tableu on 66th Republic Day parade

2016

Improving Access

By 2016, Panacea had left no stone unturned to improve access to radiotherapy with Bhabhatron II installed in Kenya, Tanzania and Kyrgyztan

2017

Kassia Award

In 2017, For its contribution, Panacea was awarded with Kassia Ujwala Prashasti Award and was certified with ZED

2018

Lilac – CE

In 2018, Bhabhatron II was installed in Uganda and Madagascar, ensuring timely treatment of cancer in these unreached areas. With Lilac getting CE marked in 2018, Panacea had empowered clinicians in the early detection of breast cancer.

2019

Linac – CE

In 2019, Panacea’s Linear Accelerator was CE marked. Panacea also received patent for its Linac’s In gantry dual kV imaging

2020

Expanding Horizon

In 2020, Panacea setup its a new state-of-art manufacturing plant in Malur and started its US operations in Indiana, USA as part of its expansion plan to cater to the increasing needs of Radiotherapy. Panacea also installed Bhabhatron MLC in Varanasi and Madurai

2021

USFDA 510(k) received for Siddharth-II

In 2021, Panacea received USFDA 510(k) clearance for Linear Accelerator- Siddharth-II.

2023

Type approval & clinical licence received for Siddharth-II

Panacea received Type Approval and Clinical Licence from AERB for its Linear Accelerator- Siddharth-II in 2023. Panacea also received US 510(k) clearance of Siddharth-II integrated with RFA.

Our Story

Our Innovation History​

1999

Establishment

2002

Development of MV Linac

2005

Commissioning of Bhabhatron

2006

1st Installation

2008

Recognition

2009

CE Certification

2010

Vietnam

2011

R&D Facility

2012

Excellence

2013

Quality Award

2014

Treating Lives

2015

66th Republic Day

2016

Improving Access

2017

Kassia Award

2018

Lilac – CE

2019

Linac – CE

2020

Expanding Horizon

2021

USFDA 510(k) received for Siddharth-II

2023

Type approval & clinical licence received for Siddharth-II

BOARD OF DIRECTORS

Mr. G.V. Subrahmanyam

Mr. Y Ramann

Mrs. Valli

Mrs. Bala Deshpande

Mr. Tarun Sharma

Mr. Charles-Antoine Janssen

Connect with Panacea

Privacy Policy

Terms of Use

Our Innovation History